Harnessing the Microbiome: Advancing Innovations in Cancer Therapy
Introduction Cancer treatment is rapidly evolving, with the human microbiome now recognized as a key determinant in therapeutic response and patient outcomes. The 16th World Probiotics, Nutrition & Gut Health Conference and Exhibition , taking place on December 10–11, 2026, in Kuala Lumpur, Malaysia, will feature Track 21: Microbiome Modulation in Cancer Therapy, highlighting the latest scientific advancements in this transformative area of oncology. The Role of the Microbiome in Oncology The gut microbiome plays an essential role in regulating immune function, inflammation, and metabolic pathways. Recent scientific evidence demonstrates that the composition and diversity of gut microbiota can significantly influence the effectiveness of cancer treatments, including immunotherapy, chemotherapy, and radiotherapy. This growing body of research positions the microbiome as a promising target for optimizing therapeutic outcomes. Emerging Therapeutic Strategies Innovative approache...